StockWatch
·
Biotechnology: Pharmaceutical Preparations
Business UpdateJul 20, 2026, 04:57 PM

Organigram Reports Strong Sanity Performance, Canadian Market Share Gains

AI Summary

Organigram Global Inc. provided a business update highlighting the initial operating performance of its acquired Sanity Group and continued strength in its Canadian market share. Sanity Group has maintained approximately 10% market share in Germany and performed in line with revenue expectations since its acquisition in April 2026. In Canada, Organigram continues to lead in flower and vape categories, with overall recreational cannabis market share improving sequentially in June. The company also announced it expects to report its Q3 Fiscal 2026 results, including Sanity's financials, around August 11, 2026, and will host a Digital Investor Session in late September 2026.

Key Highlights

  • Sanity Group maintained ~10% market share in Germany since April 15, 2026 acquisition.
  • Sanity's performance aligned with revenue expectations at the time of acquisition.
  • Organigram holds #1 market share in Canadian flower (12.5%) and vapes (14.5%).
  • Organigram is #2 in Canadian pre-rolls with 7.3% market share.
  • Canadian market share improved 100 basis points sequentially in June versus May.
  • Recorded year-over-year market share gains in beverages (+3.1 percentage points) and concentrates (+3.3 percentage points).
  • Q3 Fiscal 2026 results, including Sanity, expected around August 11, 2026.
  • Digital Investor Session planned for late September 2026 to discuss long-term strategy.